Novavax’s Vaccine Switched Manufacturing Facilities Multiple Times Prior To EUA

vaccine manufacturing
Novavax told the FDA of a manufacturing change late in the review of the EUA request for its COVID-19 vaccine . • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance